Avantor opens logistics hub
Avantor has opened a logistics hub in Westminster, MA, to strengthen the company's global biopharma supply chain. The new facility serves as a center for raw material storage, quality control, and distribution to support the growth of Avantor's single-use solutions. Read More
Alethiomics launches to advance multiomics target discovery pipeline
Alethiomics, a drug discovery company focused on developing targeted therapies to treat myeloproliferative neoplasms, launched with 6 million euros ($6.8 million) in seed financing from Oxford Science Enterprises. The company is a spinoff from the University of Oxford. Read More
Gretel, Illumina partner to develop synthetic data for genomic research
Gretel announced a collaboration with Illumina to create synthetic genomic data that can be accessed by medical researchers globally. The companies also announced the release of a case study the partnership conducted that explores significant new use cases for synthetic data in genomics and related fields, including medical diagnosis, biotechnology, forensic biology, virology, and biological systematics. Read More
Valence Discovery acquires $8.5M in seed funding for chemistry engine
Valence Discovery has closed an oversubscribed $7 million seed funding round. The financing adds to $1.5 million that was raised previously, bringing Valence's total funding to $8.5 million. Read More
Synthetic Biologics acquires VCN Biosciences
Synthetic Biologics has signed a definitive agreement to acquire VCN Biosciences. Total upfront consideration for the acquisition is $4.7 million in cash plus the assumption of $2.4 million of VCN liabilities. The transaction is expected to close during the first quarter of 2022. Read More
Opentrons' subsidiary Neochromosome and Mekonos announce partnership
Opentrons' subsidiary Neochromosome and Mekonos have formed a new partnership to advance cell engineering for personalized cell therapies. Read More
CellCarta acquires Biogazelle
CellCarta announced the acquisition of Biogazelle to strengthen its genomic capabilities and expand into digital polymerase chain reaction services. Read More
Elemental Machines acquires Tetra Lab Monitoring
Elemental Machines has acquired the Tetra Lab Monitoring business, including key hardware, talent, and novel asset integrations from TetraScience. The acquisition strengthens Elemental Machines' leadership in the field of laboratory asset management technology, the company said. Read More
Catamaran Bio presents preclinical data for CAR-NK cell therapy
Catamaran Bio has reported preclinical data that demonstrate the capabilities of its Tailwind platform being applied to develop CAT-248, an allogeneic CD70-targeted CAR-NK cell therapy. Read More
Akoya Biosciences, PathAI collaborate on novel predictive biomarkers
Akoya Biosciences is collaborating with PathAI to advance the discovery and validation of novel predictive biomarkers for immunotherapies. The collaboration will explore spatial biology and deep data mining using Phenoptic, Akoya's high-throughput spatial phenotyping platform, and PathAI's artificial intelligence (AI) tools and algorithms to identify the patients who are most likely to respond to drug therapy in clinical trials. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
